Nonalcoholic Steatohepatitis and the Cardiometabolic Syndrome
Authors:
- 1 January 2006
- journal article
- Published by Wiley in Journal of the CardioMetabolic Syndrome
- Vol. 1 (1) , 36-40
Abstract
Nonalcoholic fatty liver disease (NAFLD) is now considered to be the most common liver disease in the United States and involves a spectrum of progressive histopathologic changes. Common risk factors associated with NAFLD include obesity, diabetes, and hyperlipidemia. Although most patients with NAFLD have simple hepatic steatosis, a significant number develop nonalcoholic steatohepatitis , which may progress to fibrosis, cirrhosis, or end‐stage liver disease. There is increasing evidence that NAFLD is a common feature in patients with the cardiometabolic syndrome, a constellation of metabolic , cardiovascular, renal, and inflammatory abnormalities in which insulin resistance is thought to play a key role in end‐organ pathogenesis. NAFLD is usually diagnosed after abnormal liver chemistry results are found during routine laboratory testing. No therapy has been proven effective for treating NAFLD/nonalcoholic steatohepatitis. Expert opinion emphasizes the importance of exercise, weight loss in obese and overweight individuals, treatment of hyperlipidemia, and glucose control.Keywords
This publication has 41 references indexed in Scilit:
- Non-alcoholic steatohepatitis: From cell biology to clinical practiceJournal of Hepatology, 2006
- The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver DiseaseAnnals of Internal Medicine, 2005
- Lessons from animal models of NASHHepatology Research, 2005
- Pathology of nonalcoholic steatohepatitisHepatology Research, 2005
- Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver diseaseScandinavian Journal of Gastroenterology, 2005
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- AGA technical review on nonalcoholic fatty liver diseaseGastroenterology, 2002
- Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2002
- Update on the cardiometabolic syndromeClinical Cornerstone, 2001
- FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATUREMedicine, 1962